⌘K

Home/Filings/4/0001181431-13-016068

4//SEC Filing

FRACTOR DAVID 4

Accession 0001181431-13-016068

CIK 0000822411other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 5:35 PM ET

Size

5.4 KB

Accession

0001181431-13-016068

Insider Transaction Report

Form 4

Period: 2013-03-07

ImmunoCellular Therapeutics, Ltd.IMUC

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2013-03-07−64,000→ 64,000 total
Exercise: $2.72Exp: 2020-02-29→ Common Stock (64,000 underlying)

Footnotes (1)

[F1]The option vests in one annual installment of 16,000 shares on March 1, 2014 and in equal monthly installments for the three years thereafter.

Documents

1 file

4
rrd373037.xmlPrimary
PRIMARY DOCUMENT

Issuer

ImmunoCellular Therapeutics, Ltd.

CIK 0000822411

Entity typeother

Related Parties

1

filerCIK 0001215025

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 5:35 PM ET
Size: 5.4 KB

View on SEC.gov